Have Vita Life Sciences Insiders Been Selling Stock?
We note that the Vita Life Sciences Limited (ASX:VLS) Non-Executive Chairman, Henry Townsing, recently sold AU$83k worth of stock for AU$2.76 per share. On the bright side, that's just a small sale and only reduced their holding by 6.4%.
The Last 12 Months Of Insider Transactions At Vita Life Sciences
In fact, the recent sale by Non-Executive Chairman Henry Townsing was not their only trade of Vita Life Sciences shares this year. Earlier in the year, they spent AU$319k to buy shares at AU$2.45 per share. Although we like to see insider buying, we note that this large purchase was at significantly below the recent price of AU$2.77. Because the shares were purchased at a lower price, this particular buy doesn't tell us much about how insiders feel about the current share price.
In the last twelve months insiders purchased 134.00k shares for AU$328k. But they sold 123.88k shares for AU$313k. Overall, Vita Life Sciences insiders were net buyers during the last year. You can see the insider transactions (by companies and individuals) over the last year depicted in the chart below. By clicking on the graph below, you can see the precise details of each insider transaction!
See our latest analysis for Vita Life Sciences
Vita Life Sciences is not the only stock that insiders are buying. For those who like to find small cap companies at attractive valuations, this free list of growing companies with recent insider purchasing, could be just the ticket.
Insider Ownership
Another way to test the alignment between the leaders of a company and other shareholders is to look at how many shares they own. We usually like to see fairly high levels of insider ownership. It appears that Vita Life Sciences insiders own 29% of the company, worth about AU$45m. This level of insider ownership is good but just short of being particularly stand-out. It certainly does suggest a reasonable degree of alignment.
So What Does This Data Suggest About Vita Life Sciences Insiders?
An insider sold stock recently, but they haven't been buying. But we take heart from prior transactions. And insiders do own shares. So we're happy enough to look past some selling. In addition to knowing about insider transactions going on, it's beneficial to identify the risks facing Vita Life Sciences. You'd be interested to know, that we found 1 warning sign for Vita Life Sciences and we suggest you have a look.
If you would prefer to check out another company -- one with potentially superior financials -- then do not miss this free list of interesting companies, that have HIGH return on equity and low debt.
For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.